John,

This morning, SCOTUS released their opinion in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine, and in a unanimous decision, the Court declined to further restrict mifepristone. For now, access to medication abortion will remain unchanged.

It’s not often that we get to breathe a sigh of relief for abortion providers and pregnant patients, so today, we’ll take it. But this opinion does not guarantee anything in perpetuity – only that this particularly case was not successful in its attempt to attack abortion.

We have to be honest: the fact that this case even reached the Supreme Court shows just how dire our situation is.

Mifepristone is used in two-thirds of all abortions nationally. It’s incredibly safe, and it’s been on the market for decades. The fact that a Trump-appointed federal judge ruled to strip mifepristone of its FDA approval is unhinged, and it’s an indication of escalating attacks from every angle.

Nevertheless, we’re clear-eyed about what we’re up against. In recent weeks, we’ve seen renewed attacks on IVF and efforts in state legislatures to classify abortion medication as a “controlled substance.” Our work to elect pro-choice champions at the state and local level is absolutely critical to the future of reproductive rights.

This work is made possible by supporters like you, and a gift of any amount helps us fight back in city halls, court houses, and state legislatures across the country.

Thank you for being in this movement,

Sara Tabatabaie
Executive Director
Vote Pro-Choice